Loading Events

« All Events

Vaccines targeting COVID-19

17. November @ 14:00 - 16:20

Setting the landscape: are we close? Can the
development be safely accelerated?

 

Free Virtual Seminar, sign up via the form below.

 

 

We are in the middle of a historic pandemic. Researchers around the globe are
working intensely to launch a vaccine targeting the COVID-19 virus. A scientific,
political and commercial race, raising numerous questions. How can a development
process, that usually takes up to 10 years suddenly be shortened to less than 2 years?
This, without compromising safety? Who are the primary target groups? Which
pharmaceutical technologies are currently being exploited to design the COVID-19
vaccine and how close are we actually to launch of a safe and effective vaccine?

 

PROGRAM

  • 14.00-14.05 Welcome by Danish Pharmaceutical Society
    Stine Harloff-Helleberg, Assistant Professor, Dept. of Pharmacy, UCPH/
    Danish Pharmaceutical Society

 

  • 14.05-14.25 Status from the clinic: what is needed from a COVID-19 vaccine?
    Thomas Benfield, Professor of Infectious Diseases, Hvidovre Hospital

 

  • 14.30-15.00 Vaccine technologies: how close are we?
    Ali Salanti, Professor, Dept. of Immunology and Microbiology, UCPH

 

  • 15.05-15.35 Can the development process be safely accelerated?
    Nikolaj Brun, Director of Division Medical Evaluation and Biostatistics,
    Danish Medicines Agency

 

  • 15.40-16.00 How should we evaluate potential long-term effects?
    Christine Stabell Benn, Clinical Professor, Uni. of Southern Denmark

 

  • 16.05-16.20 Discussion and wrap up
    Steen Ingwersen & Lise Sylvest Helledi,
    Danish Pharmaceutical Society/ Novo Nordisk
    Registration via www.farmaceutisk-selskab.dk.

 

 

 

 

Details

Date:
17. November
Time:
14:00 - 16:20

Venue

Virtual

Organizer

Biofarmacisektionen

Details

Date:
17. November
Time:
14:00 - 16:20

Venue

Virtual

Organizer

Biofarmacisektionen